Table 2 Quality and quantity of tumor lysate-loaded DCs
Patient ID | Tumor lysate used for EP (mg) | DCs used for EP (x107) | Tumor lysate (mg)/ 107DCs | Number of DCs injected | Viability (%) |
|---|---|---|---|---|---|
1802 | 15 | 29.5 | 0.51 | 1x107 | 82.9 |
1803 | 15 | 18.3 | 0.82 | 1x107 | 82.1 |
1806 | 20 | 17.1 | 1.17 | 1x107 | 92.8 |
1808 | 7 | 16.0 | 0.44 | 1x107 | 83.6 |
1812 | 20 | 20.1 | 1.00 | 1x107 | 89.0 |
1814 | 20 | 21.5 | 0.93 | 1x107 | 91.7 |
1817 | 20 | 20.0 | 1.00 | 1x107 | 87.5 |
1823 | 20 | 15.0 | 1.33 | 0.5 x107 | 92.4 |